AP2006003784A0 - Novel compositions for topical delivery - Google Patents

Novel compositions for topical delivery

Info

Publication number
AP2006003784A0
AP2006003784A0 AP2006003784A AP2006003784A AP2006003784A0 AP 2006003784 A0 AP2006003784 A0 AP 2006003784A0 AP 2006003784 A AP2006003784 A AP 2006003784A AP 2006003784 A AP2006003784 A AP 2006003784A AP 2006003784 A0 AP2006003784 A0 AP 2006003784A0
Authority
AP
ARIPO
Prior art keywords
novel compositions
topical delivery
topical
delivery
compositions
Prior art date
Application number
AP2006003784A
Other languages
English (en)
Inventor
Kour Chand Jindal
Sukhjeet Singh
Vaibhav Sihorkar
Rajesh Jain
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of AP2006003784A0 publication Critical patent/AP2006003784A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2006003784A 2004-03-18 2005-03-17 Novel compositions for topical delivery AP2006003784A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN501DE2004 2004-03-18
PCT/IN2005/000086 WO2005087195A2 (en) 2004-03-18 2005-03-17 Novel compositions for topical delivery

Publications (1)

Publication Number Publication Date
AP2006003784A0 true AP2006003784A0 (en) 2006-10-31

Family

ID=34976285

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003784A AP2006003784A0 (en) 2004-03-18 2005-03-17 Novel compositions for topical delivery

Country Status (10)

Country Link
US (1) US20080050434A1 (pt)
EP (1) EP1734925A2 (pt)
AP (1) AP2006003784A0 (pt)
AU (1) AU2005221427B2 (pt)
BR (1) BRPI0508933A (pt)
CA (1) CA2559351A1 (pt)
EA (1) EA011244B1 (pt)
RS (1) RS20060479A (pt)
WO (1) WO2005087195A2 (pt)
ZA (1) ZA200608621B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2005214A3 (cs) * 2005-04-06 2006-10-11 Zentiva, A. S. Topická léková forma s obsahem nimesulidu
MXPA05010457A (es) * 2005-09-28 2007-03-27 Fernando Ahumada Ayala Preparacion para el tratamiento de enfermedades inflamatorias de la piel, que contiene tacrolimus.
WO2007117002A1 (ja) * 2006-04-07 2007-10-18 Riken 殺虫殺卵組成物及び殺虫殺卵方法
HUE033011T2 (hu) 2007-05-30 2017-11-28 Veloxis Pharmaceuticals As Takrolimuszt tartalmazó napi egyszeri orális dózisforma
US12083103B2 (en) 2007-05-30 2024-09-10 Veloxis Pharmaceuticals, Inc. Tacrolimus for improved treatment of transplant patients
US20100183519A1 (en) * 2007-06-08 2010-07-22 University Of Virginia Patent Foundation Topical Poloxamer Formulations for Enhancing Microvascular Flow: Compositions and Uses Thereof
WO2009010986A1 (en) * 2007-07-19 2009-01-22 Glenmark Pharmaceuticals Limited Topical cream compositions of sertaconazole nitrate
US12403095B2 (en) 2008-05-30 2025-09-02 Veloxis Pharmaceuticals, Inc. Stabilized tacrolimus composition
CA2731455A1 (en) * 2008-07-23 2010-01-28 Gregor Cevc Methods of administering topical antifungal formulations for the treatment of fungal infections
WO2010041684A1 (ja) * 2008-10-08 2010-04-15 高田製薬株式会社 タクロリムス外用剤
WO2010109418A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal cream and a process to make it
WO2010109425A2 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal steroids cream and a process to make it
WO2010119365A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using clotrimazole and chitosan and a process to make the same
WO2010119368A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using miconazole nitrate and chitosan, and a process to make the same
WO2010119386A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using clotrimazole, fluticasone propionate, and chitosan, and a process to make the same
WO2010119387A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using miconazole nitrate, fluticasone propionate, and chitosan, and a process to make the same
WO2011027247A1 (en) * 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
WO2011027246A1 (en) * 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi A cream comprising miconazole nitrate and a biopolymer for the treatment of diaper rash
BR112012006808A2 (pt) * 2009-10-02 2019-09-24 Yissum Research Development Co Of The Hebrew Univ Of Jerusalem "composições sanitizadoras e método para sanitização de superfície"
TWI510238B (zh) 2010-02-17 2015-12-01 Lifecycle Pharma As 穩定化他克莫司（ｔａｃｒｏｌｉｍｕｓ）組合物
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation
US11806427B2 (en) * 2014-09-17 2023-11-07 Alps South Europe, S.R.O. Topical composition containing antioxidants
WO2016077556A1 (en) * 2014-11-12 2016-05-19 Research Foundation Of The City University Of New York Environmentally friendly gelator using medium chain triglycerides and method of use
WO2016094617A1 (en) * 2014-12-11 2016-06-16 Phosphorex, Inc. Aqueous topical drug formulation with controlled release and increased stability
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
PT3297605T (pt) 2015-05-21 2022-05-30 Dermavant Sciences GmbH Composições farmacêuticas tópicas
CN106967536B (zh) * 2017-03-29 2019-04-02 东北石油大学 砂岩类原油驱替实验岩心洗油剂及其制备方法
CN113440483B (zh) * 2021-06-30 2023-04-07 佛山市南海东方澳龙制药有限公司 一种犬用盐酸特比萘芬喷剂及其制备方法
CN116077421B (zh) * 2023-01-03 2023-12-12 江苏知原药业股份有限公司 一种他克莫司软膏及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026917A1 (en) * 1996-01-23 1997-07-31 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Composition for treating skin affections and process for its preparation
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent

Also Published As

Publication number Publication date
RS20060479A (sr) 2008-11-28
WO2005087195A2 (en) 2005-09-22
BRPI0508933A (pt) 2007-08-14
US20080050434A1 (en) 2008-02-28
EP1734925A2 (en) 2006-12-27
WO2005087195A3 (en) 2006-08-03
EA200601724A1 (ru) 2007-02-27
CA2559351A1 (en) 2005-09-22
AU2005221427B2 (en) 2008-09-25
EA011244B1 (ru) 2009-02-27
AU2005221427A1 (en) 2005-09-22
ZA200608621B (en) 2008-06-25

Similar Documents

Publication Publication Date Title
AP2006003784A0 (en) Novel compositions for topical delivery
GB0424891D0 (en) Topical compositions
GB0524962D0 (en) Topical pharmaceutical compositions
IL247484A0 (en) Gel preparations for local administration
EP1765283A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0409703D0 (en) Pharmaceutical compositions
GB0408308D0 (en) Pharmaceutical compositions
ZA200904425B (en) Nemathical compositions
EP1718714A4 (en) COMPOSITIONS CONTAINING A PLOTTER
GB0817929D0 (en) Compositions for topical treatment
GB0405033D0 (en) Novel pharmaceutical compositions
GB0405406D0 (en) Anti-vaginitis compositions
GB0406378D0 (en) Novel pharmaceutical compositions
PL1888024T3 (pl) Preparat miejscowy
PL1824450T3 (pl) Kompozycje do podawania donosowego
GB0406380D0 (en) Novel pharmaceutical compositions
EP1805154A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA200701197B (en) Compositions
GB0410140D0 (en) Compositions
GB0407351D0 (en) Pharmaceutical compositions
GB0425445D0 (en) Novel compositions
GB0420627D0 (en) Monoglyceride-containing compositions
GB0400971D0 (en) Pharmaceutical compositions
GB0516558D0 (en) Topical compositions
GB0519213D0 (en) Compositions for intranasal administration